May Khanna, Ph.D.

Affiliations: 
2014-2021 Pharmacology University of Arizona, Tucson, AZ 
Area:
Chemical Biology
Website:
https://maykhanna.wixsite.com/themaykhannalab
Google:
"May Khanna"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cai S, Moutal A, Yu J, et al. (2021) Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents. Science Translational Medicine. 13: eabh1314
Francois-Moutal L, Scott DD, Khanna M. (2021) Direct targeting of TDP-43, from small molecules to biologics: the therapeutic landscape. Rsc Chemical Biology. 2: 1158-1166
François-Moutal L, Miranda VG, Mollasalehi N, et al. (2021) Targeting of the Long Noncoding RNA MALAT1. Acs Medicinal Chemistry Letters. 12: 915-921
Mollasalehi N, Francois-Moutal L, Scott DD, et al. (2020) An Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43 Yields Neuroprotective Properties. Acs Chemical Biology
François-Moutal L, Perez-Miller S, Scott DD, et al. (2020) Corrigendum: Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Frontiers in Molecular Neuroscience. 13: 45
Kump KJ, Miao L, Mady ASA, et al. (2020) Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-Apoptotic Mcl-1 and Bfl-1 Proteins. Journal of Medicinal Chemistry
Kump KJ, Miao L, Mady AA, et al. (2020) Abstract LB-226: Discovery of small molecule Mcl-1 and Bfl-1 inhibitors Cancer Research. 80
François-Moutal L, Perez-Miller S, Scott DD, et al. (2019) Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Frontiers in Molecular Neuroscience. 12: 301
Zhou Y, Cai S, Moutal A, et al. (2019) The natural flavonoid Naringenin elicits analgesia through inhibition of NaV1.8 voltage-gated sodium channels. Acs Chemical Neuroscience
Moutal A, Shan Z, Miranda VG, et al. (2019) Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief. Channels (Austin, Tex.). 13: 498-504
See more...